Biodexa Pharmaceuticals (BDRX) FCF Margin (2015 - 2021)
Biodexa Pharmaceuticals (BDRX) posted FCF Margin of 87487.5% for Q4 2020, little changed sequentially from 87487.5% in Q3 2020, and down 8551315.0% YoY from N/an in Q1 2020.
Biodexa Pharmaceuticals (BDRX) FCF Margin (2015 - 2021) Analysis & Trends
Biodexa Pharmaceuticals has reported FCF Margin for 4 years, with the latest figure at 87487.5% in Q4 2020.
- Quarterly FCF Margin fell 8551315.0% year-over-year to 87487.5% in Q4 2020, while the trailing twelve-month figure through Dec 2020 was 1866.94% (changed N/A YoY) and the FY2023 annual result came in at 1784.78%, down 78535.0% from the prior year.
- FCF Margin was little changed at 87487.5% in Q4 2020 per BDRX's latest filing, from 87487.5% in the prior quarter.
- Over five years, FCF Margin peaked at 1514.71% in Q4 2016 and troughed at 87487.5% in Q3 2020.
- A 3-year average of 44616.01% and a median of 44730.92% in 2019 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2016 and 2020: FCF Margin plunged 133436 bps in 2016, then tumbled 8551315 bps in 2020.
- Over 3 years, FCF Margin stood at 1514.71% in 2016, then slumped by 30 bps to 1974.35% in 2019, then sank by 4331 bps to 87487.5% in 2020.
- According to Business Quant data, FCF Margin over the past three periods registered 87487.5%, 87487.5%, and 1974.35% for Q4 2020, Q3 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | Biodexa Pharmaceuticals | 63,168.17 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 47.13% |
| Dec 31, 2020 | -87,487.50% |
| Sep 10, 2020 | -87,487.50% |
| Dec 31, 2019 | -1,974.35% |
| Dec 31, 2016 | -1,514.71% |
| Dec 31, 2015 | -180.35% |